10 Questions
What is the CNIC-polypill and in what context is it used?
The CNIC-polypill is a cardiovascular (CV) polypill used for secondary CV prevention in patients with atherosclerotic cardiovascular disease (CVD).
What are some of the challenges in implementing the use of the CNIC-polypill in real-world clinical practice?
Some of the challenges in implementing the use of the CNIC-polypill in real-world clinical practice include barriers in secondary CV prevention and the need to overcome these barriers for effective implementation.
According to the text, what do several guidelines state about the CV polypill and its role in CVD prevention?
Several guidelines state that a CV polypill should be considered an integral part of a comprehensive CV disease (CVD) prevention strategy.
When was the Expert Panel Meeting of the EMINENT Program held, and in what format?
The Expert Panel Meeting of the EMINENT Program was held virtually on 21 April 2022.
What is the main focus of the expert panel meeting report discussed in the text?
The main focus of the expert panel meeting report is on the opportunities and challenges in using the CNIC-polypill in real-life clinical practice for patients at very high risk of atherosclerotic cardiovascular disease.
What are the two guidelines compared in the text?
The AHA/ACC/Multisociety guidelines and the ESC/EAS guidelines on lipid management.
What are the differences between the AHA/ACC/Multisociety guidelines and the ESC/EAS guidelines in terms of risk estimation, at-risk groups, and treatment goals?
They follow different approaches in terms of methods of risk estimation, definitions of at-risk groups, and treatment goals.
What do both guidelines recommend with regard to low-density lipoprotein cholesterol (LDL-C) levels?
Both recommend achieving risk-based percentage reductions of LDL-C levels with statin therapy.
What additional recommendation does the ESC/EAS guidelines provide regarding LDL-C levels?
The ESC/EAS guidelines additionally recommend target LDL-C levels.
Who are the authors of the article?
Maninder Singh, MBBS; John W. McEvoy, MBBCh; Safi U. Khan, MD; David A. Wood, MSc; Ian M. Graham, MD; Roger S. Blumenthal, MD; Abhishek K. Mishra, MBBS; and Erin D. Michos, MD, MHS
Test your knowledge of the CNIC-Polypill and its use in real-life clinical practice for patients at high risk of atherosclerotic cardiovascular disease. This quiz covers expert panel meeting insights and the opportunities and challenges associated with the use of CNIC-Polypill. Gain a deeper understanding of this innovative approach to managing cardiovascular health.
Make Your Own Quizzes and Flashcards
Convert your notes into interactive study material.
Get started for free
